Market Overview

UPDATE: Jefferies & Company Reiterates Hold Rating, Lowers PT on Allscripts Healthcare Solutions

Related MDRX
New Survey Gives J.P. Morgan Confidence To Go Overweight Athenahealth, Allscripts & Advisory Board
Cookeville Medical Center Selects Allscripts for Chronic Care Management (CCM) Program
3 Industry Groups Show Strength, Rise Through Ranks (Investor's Business Daily)

In a report published Friday, Jefferies & Company reiterated its Hold rating on Allscripts Healthcare Solutions (NASDAQ: MDRX), but lowered its price target from $13.00 to $10.00.

Jefferies noted, “This morning's call revealed few additional details of the bidding process and outcome. Deal will not bail investors out of this name in 2012. MDRX's new management seems intent on executing the existing strategy: offering an integrated solution and building out its service portfolio. After today's trading the stock is cheap, but we would like to see evidence of traction to ensure EBITDA doesn't shrink further.”

Allscripts Healthcare Solutions closed on Thursday at $9.14.

Latest Ratings for MDRX

Nov 2015JP MorganAssumesOverweight
Nov 2015Deutsche BankMaintainsBuy
Nov 2015Leerink SwannMaintainsMarket Perform

View More Analyst Ratings for MDRX
View the Latest Analyst Ratings

Posted-In: Jefferies & CompanyAnalyst Color Price Target Analyst Ratings


Related Articles (MDRX)

Get Benzinga's Newsletters